C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/04 (2006.01) A61K 31/435 (2006.01) A61K 45/06 (2006.01) C07D 519/00 (2006.01)
Patent
CA 2456817
Compounds represented by Formula (I) or a pharmaceutically acceptable salt thereof, are phosphodiesterase 4 inhibitors useful in the treatment of asthma and inflammation.
L'invention concerne des composés représentés par la formule (I), y compris leurs sels pharmaceutiquement acceptables. Il s'agit d'inhibiteurs de phosphodiestérase 4, utiles pour le traitement de l'asthme et de l'inflammation.
Friesen Richard
Girard Mario
Guay Daniel
Hamel Pierre
Laliberte Sebastien
Merck Frosst Canada & Co./merck Frosst Canada & Cie
Merck Frosst Canada Ltd.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Alkyne-aryl-naphthyridin-4 (1h)-one derivatives as type iv... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alkyne-aryl-naphthyridin-4 (1h)-one derivatives as type iv..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkyne-aryl-naphthyridin-4 (1h)-one derivatives as type iv... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1407085